Effect of HIV on the distribution of NK cell subsets and their phenotype in infants pre-ART initiation and at 10 months of age

International Workshop on HIV Pediatrics 2021

Impact of COVID-19 on Ugandan children with and without HIV

International Workshop on HIV Pediatrics 2021

Ritonavir concentrations in hair predict virological outcomes in HIV-infected adolescents with virological treatment failure to atazanavir/ritonavir-based second-line treatment

International Workshop on HIV Pediatrics 2021

IMARA SA: Piloting a family-based HIV/STI prevention package for South African adolescent girls and young women

International Workshop on HIV Pediatrics 2021

Using Narrative Films to Combat HIV-Related Stigma in Western Kenya: A Pilot Study of Adolescents Living with HIV and their Caregivers

International Workshop on HIV Pediatrics 2021

Tenofovir, Lamivudine and Dolutegravir (TLD) among Rural Adolescents in Zimbabwe, a Cautionary Tale.

International Workshop on HIV Pediatrics 2021

Feasibility and Acceptability of a Peer Youth Led Curriculum to Improve HIV Knowledge in Northern Tanzania: Resilience and Intervention Experience from the Perspective of Peer Leaders

International Workshop on HIV Pediatrics 2021

Trends in HIV self-testing among adolescent and youth populations across sub-Saharan Africa

International Workshop on HIV Pediatrics 2021

Lopinavir Drug Exposures in African Children with HIV using Lopinavir/ritonavir Pellets Dosed per WHO Weight-Bands

International Workshop on HIV Pediatrics 2021

Exposure to two dolutegravir formulations in children in the ODYSSEY trial

International Workshop on HIV Pediatrics 2021

Abacavir Weight-Band Dosing for Infants in the First 4 Weeks of Life

International Workshop on HIV Pediatrics 2021

Assessing parental choice of Lopinavir/ritonavir granules intake to improve child adherence at Baylor-Mwanza, Tanzania.

International Workshop on HIV Pediatrics 2021

Caregivers perception on paedriatic Lopinavir/ritonavir formulations for HIV infected children at Baylor clinic, Mwanza-Tanzania.

International Workshop on HIV Pediatrics 2021

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Fumarate (E/C/F/TAF) on Bone Safety Parameters in Children and Adolescents Living with HIV

International Workshop on HIV Pediatrics 2021

Effect of dolutegravir on folate and vitamin B12 status among HIV-infected children and adolescents in the ODYSSEY trial

International Workshop on HIV Pediatrics 2021

Neuropsychiatric manifestations and sleep disturbances in children and adolescents randomised to dolutegravir-based ART vs standard-of-care in the ODYSSEY trial

International Workshop on HIV Pediatrics 2021

Mutations associated with ineffectiveness of HIV-1 protease inhibitors in children in Abidjan, Côte d'Ivoire

International Workshop on HIV Pediatrics 2021

Early Trends in HIV Drug Resistance Mutations Among Pediatric and Young Adult (0-24 years) Clients in Sub-Saharan Africa

International Workshop on HIV Pediatrics 2021

HIV Drug Resistance Patterns Among Highly Treatment-Experienced Children, Adolescents and Young Adults in Sub-Saharan Africa

International Workshop on HIV Pediatrics 2021

The road to success is paved with dolutegravir: Dolutegravir treatment success among in children and adolescents living with HIV (CALHIV) at the Baylor Tanzania Centres of Excellence.

International Workshop on HIV Pediatrics 2021

Successful Scale- Up of Optimal Antiretroviral Regimens and Improvement in Viral Suppression for Children and Adolescents Living with HIV Amidst COVID 19 Pandemic In Kenya

International Workshop on HIV Pediatrics 2021

Challenges in the effective treatment of infant HIV undermine the potential impact of birth testing and neonatal ART: preliminary results from the LIFE trial in Mozambique and Tanzania

International Workshop on HIV Pediatrics 2021

Adolescent and caregiver perspectives on an enhanced adherence counseling intervention for youth with suspected HIV treatment failure in Kenya

International Workshop on HIV Pediatrics 2021

Adherence to Antiretroviral Therapy among Children Living with HIV in North-Central Nigeria: a Qualitative Evaluation of Barriers and Facilitators among Caregivers

International Workshop on HIV Pediatrics 2021